Similar articles

• Uric Acid Is a Risk Indicator for Metabolic Syndrome-related Colorectal Adenoma: Results in a Korean Population Receiving Screening Colonoscopy.

  Kim HJ, Kim JE, Jung JH, Kim ER, Hong SN, Chang DK, Son HJ, Rhee PL, Kim JJ, Kim YH. Kim HJ, et al. Korean J Gastroenterol. 2015 Oct;66(4):202-8. doi: 10.4166/kjg.2015.66.4.202. Korean J Gastroenterol. 2015. PMID: 26493505
• Uric Acid, Metabolic Syndrome and Atherosclerosis: The Chicken or the Egg, Which Comes First?

  De Pergola G, Cortese F, Termine G, Meliota G, Carbonara R, Masiello M, Cortese AM, Silvestris F, Caccavo D, Ciccone MM. De Pergola G, et al. Endocr Metab Immune Disord Drug Targets. 2018;18(3):251-259. doi: 10.2174/1871530318666180212101548. Endocr Metab Immune Disord Drug Targets. 2018. PMID: 29437024
• Effectiveness of repeated screening using the fecal occult blood test and its impact on reducing false-negative cancer cases.

  Nishida H, Urano S. Nishida H, et al. Eur J Cancer Prev. 2011 May;20(3):184-9. doi: 10.1097/CEJ.0b013e3283447453. Eur J Cancer Prev. 2011. PMID: 21301345
• Advanced technology for the improvement of adenoma and polyp detection during colonoscopy.

  Moriyama T, Uraoka T, Esaki M, Matsumoto T. Moriyama T, et al. Dig Endosc. 2015 Apr;27 Suppl 1:40-4. doi: 10.1111/den.12428. Dig Endosc. 2015. PMID: 25556542 Review.
• Why focus on uric acid?

  Johnson RJ. Johnson RJ. Curr Med Res Opin. 2015;31 Suppl 2:3-7. doi: 10.1185/03007995.2015.1087979. Curr Med Res Opin. 2015. PMID: 26414730 Review.